Nominations--February-March 1973

Nominations--February-March 1973
Author :
Publisher :
Total Pages : 204
Release :
ISBN-10 : LOC:00100995104
ISBN-13 :
Rating : 4/5 (04 Downloads)

Synopsis Nominations--February-March 1973 by : United States. Congress. Senate. Committee on Commerce

CIS Annual

CIS Annual
Author :
Publisher :
Total Pages : 850
Release :
ISBN-10 : OSU:32437000617387
ISBN-13 :
Rating : 4/5 (87 Downloads)

Synopsis CIS Annual by :

CIS/annual

CIS/annual
Author :
Publisher :
Total Pages : 852
Release :
ISBN-10 : UVA:X001564452
ISBN-13 :
Rating : 4/5 (52 Downloads)

Synopsis CIS/annual by : Congressional Information Service

Bibliographic Guide to Government Publications

Bibliographic Guide to Government Publications
Author :
Publisher :
Total Pages : 874
Release :
ISBN-10 : MINN:31951D03045018Z
ISBN-13 :
Rating : 4/5 (8Z Downloads)

Synopsis Bibliographic Guide to Government Publications by : New York Public Library. Research Libraries

National Union Catalog

National Union Catalog
Author :
Publisher :
Total Pages : 616
Release :
ISBN-10 : UOM:39015082929715
ISBN-13 :
Rating : 4/5 (15 Downloads)

Synopsis National Union Catalog by :

Includes entries for maps and atlases.

American Book Publishing Record Cumulative, 1950-1977

American Book Publishing Record Cumulative, 1950-1977
Author :
Publisher :
Total Pages : 2530
Release :
ISBN-10 : STANFORD:36105117254248
ISBN-13 :
Rating : 4/5 (48 Downloads)

Synopsis American Book Publishing Record Cumulative, 1950-1977 by : R.R. Bowker Company. Department of Bibliography

Pharmaceutical R&D

Pharmaceutical R&D
Author :
Publisher : DIANE Publishing
Total Pages : 380
Release :
ISBN-10 : 0788104683
ISBN-13 : 9780788104688
Rating : 4/5 (83 Downloads)

Synopsis Pharmaceutical R&D by :

Analyzes the costs, risks, and economic rewards of pharmaceutical R&D and the impact of public policy on both costs and returns. Examines the rapid increase in pharmaceutical R&D that began in the 1980s in the light of trends in science, technology, drug discovery, and health insurance coverage; Government regulation; product liability; market competition; Federal tax policy; and Federal support of prescription drug research. 12 appendices, including a glossary of terms.